Long-term laboratory trends in patients with moderate-to-severe atopic dermatitis treated with upadacitinib: 140-week results from measure up 1 and 2 Meeting Abstract

publication date

  • August 1, 2026

webpage

published in

start page

  • S80

end page

  • S80

volume

  • 146

issue

  • 8